Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.

about

Treatment of allergic children - Where is the progress (for the practicing allergist)?An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis.Clinical efficacy of combined topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in the dry eyes with meibomian gland dysfunction.

P2860

Q38809512-1D9EBF84-0518-45E1-BEB6-1E31664369FD Q38909557-52C14A44-34A4-41E9-96B4-1FDBC110EA9F Q55091063-FC3C5CF2-459C-4FC2-B3FD-C95659D89376

P2860

Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.

Item

http://www.wikidata.org/entity/Q48048235

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Tacrolimus vs. cyclosporine ey ...... double-blind, crossover study.

@en

Tacrolimus vs. cyclosporine ey ...... double-blind, crossover study.

@nl

type

Item

label

Tacrolimus vs. cyclosporine ey ...... double-blind, crossover study.

@en

Tacrolimus vs. cyclosporine ey ...... double-blind, crossover study.

@nl

prefLabel

Tacrolimus vs. cyclosporine ey ...... double-blind, crossover study.

@en

Tacrolimus vs. cyclosporine ey ...... double-blind, crossover study.

@nl

P1476

Tacrolimus vs. cyclosporine ey ...... double-blind, crossover study.

@en

P2093

Annamaria Calvani

http://www.w3.org/2001/XMLSchema#string

Cinzia de Libero

http://www.w3.org/2001/XMLSchema#string

Elio Novembre

http://www.w3.org/2001/XMLSchema#string

Francesca Mori

http://www.w3.org/2001/XMLSchema#string

Laura di Grande

http://www.w3.org/2001/XMLSchema#string

Lorena di Simone

http://www.w3.org/2001/XMLSchema#string

Neri Pucci

http://www.w3.org/2001/XMLSchema#string

Simona Barni

http://www.w3.org/2001/XMLSchema#string

P2860

Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations

Ocular complications of topical, peri-ocular, and systemic corticosteroids.

Vernal keratoconjunctivitis: pathogenesis and treatment.

A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis.

Tear cytokines in acute and chronic ocular allergic inflammation.

Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors.

CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults.

Vernal keratoconjunctivitis: Result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment.

Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology.

Consensus statement on the safety profile of topical calcineurin inhibitors.

P304

256-261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PAI.12360

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Franca Rusconi

Roberto Caputo

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25712437

http://www.w3.org/2001/XMLSchema#string

Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.

about

P2860

P2860

Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698